Literature DB >> 31663375

Interleukins and miRNAs intervene in the early stages of diabetic kidney disease in Type 2 diabetes mellitus patients.

Ligia Petrica1,2, Oana Milas1, Mihaela Vlad3, Adrian Vlad4, Florica Gadalean1, Victor Dumitrascu5, Silvia Velciov1, Cristina Gluhovschi1, Flaviu Bob1, Sorin Ursoniu2,6, Dragos C Jianu7, Petru Matusz8, Agneta-Maria Pusztai8, Octavian Cretu9, Daniela Radu10, Alina Secara1, Anca Simulescu1, Maria Stefan1, Roxana Popescu11, Daliborca Vlad5.   

Abstract

Aim: The involvement of proinflammatory interleukins (IL) in diabetic kidney disease of Type 2 diabetes mellitus (DM) patients was studied in relation to a particular miRNA profile. Materials & methods: A total of 117 patients with Type 2 DM and 11 controls were enrolled in a case series study. Serum and urinary ILs and miRNAs were assessed.
Results: IL-1α correlated with miRNA21, 124, estimated glomerular filtration rate (eGFR) and negatively with miRNA125a and 192; IL-8 with miRNA21, 124, eGFR and negatively with miRNA125a, 126 and 146a; IL-18 with miRNA21, 124 and negatively with miRNA146a, 192, eGFR.
Conclusion: There is an association between specific serum and urinary ILs and serum and urinary miRNAs profiles in the inflammatory response in Type 2 DM patients with diabetic kidney disease.

Entities:  

Keywords:  albuminuria; diabetes mellitus; interleukins; miRNAs

Mesh:

Substances:

Year:  2019        PMID: 31663375     DOI: 10.2217/bmm-2019-0124

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  1 in total

1.  Target amplification-free detection of urinary microRNA for diabetic nephropathy diagnosis with electrocatalytic reaction.

Authors:  Tatchanun Ngamdee; Thanit Chalermwatanachai; Chonpiti Siriwan; Oranut Warachit; Patsamon Rijiravanich; Werasak Surareungchai
Journal:  Anal Bioanal Chem       Date:  2022-04-27       Impact factor: 4.142

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.